Discover and read the best of Twitter Threads about #DrReddysLaboratories
Most recents (1)
#DrReddysLaboratories Q3 FY22 concall highlights 💊💉
Like & Retweet for better reach !
1. Revenue for the quarter was ₹5320 Cr ($715 million). Growth of 8% YoY and declined 8% sequentially. YoY growth is due to good performance across all segments.
Like & Retweet for better reach !
1. Revenue for the quarter was ₹5320 Cr ($715 million). Growth of 8% YoY and declined 8% sequentially. YoY growth is due to good performance across all segments.
2. Sequential decline due to high base in Q2 which had a higher contribution from COVID related products.
3. Gross Profit margin for the quarter was 53.8%, increase of 40 bps QoQ. Gross margins for Global Generics were at 57.8% and PSAI were 22.5%.
3. Gross Profit margin for the quarter was 53.8%, increase of 40 bps QoQ. Gross margins for Global Generics were at 57.8% and PSAI were 22.5%.
4. SG&A spend for the quarter was ₹1541 Cr ($207 million). Increase of 7% YoY and decline of 3% QoQ. YoY increase is due to business expansion and increased spend on sales and marketing activities.
